| Management target | Revenue 35.0% FY27 |
|---|
| Revenue growth | 38% YoY growth driven by overseas operations and price hikes. |
|---|---|
| Margins | EBITDA margins expanded to 17%, driven by operational leverage and pricing. |
| Demand visibility | Strong regional demand; converters gradually resuming purchases as prices normalize. |
| Management confidence | Highly confident, emphasizing the resilience of their de-risked global model. |
Growth
Revenue grew 38% YoY to ₹53,972 million; EBITDA rose 92% YoY. Overseas operations contributed 80% of revenue and 91% of incremental EBITDA.
Outlook
Management guides 35% Revenue and EBITDA growth for FY27. Volume doubling targeted by FY29.
Risks
Normalization of high realizations from Q1; Red Sea crisis impacts on shipping; duty-free aseptic imports in India.
Last quarter's promises, checked
Delivered
- Guided H1 commissioning of Egypt aseptic plant → Delivered (Noida recycling/Mexico WPP commissioned) (= BEAT)
- Guided volume growth and improved asset utilization → Delivered 38% revenue growth (= BEAT)
- Guided EBITDA margin expansion from Q4 levels (15.3%) → Delivered 17% in Q1 FY27 (= BEAT)
Partly delivered
- Guided debt-to-EBITDA reduction from 4.35x → Delivered 3.5x (= BEAT)
- Guided 1.9k-2k Cr capex capitalization for FY26-27 → Ongoing/Partial (= PARTIAL)
Missed
- Targeted 10-10.5B aseptic packs for FY27 → Aseptic slowed due to duty-free imports (= MISS)
Earnings Call Transcript filed with NSE, NSE: UFLEX. Summary written with AI assistance from the document.
Uflex Ltd: key numbers
- Share price
- ₹639.10
- Market cap
- ₹4,615 Cr
- Revenue (annual)
- ₹15,401 Cr
- Net profit (annual)
- ₹317.1 Cr
- P/E (TTM)
- 6.8×Sector 40.4×
- Promoter holding
- 44.58%+0.00% QoQ
- FII holding
- 10.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Uflex Ltd
All →Uflex Patent
UFlex Limited received a patent from the Government of India for its 'High-Speed Twin Aseptic Pack Packaging Machine for Liquid Products'.
Uflex Other Announcement
Uflex Limited disclosed an unsolicited ESG rating of 58/100 assigned by Crisil ESG Ratings & Analytics Limited.
Uflex Investor Presentation: Key Takeaways
UFlex reported robust Q1 FY27 results with consolidated revenue of Rs. 53,972 Mn and EBITDA of Rs. 9,198 Mn. Strategy focuses on global manufacturing expansion and value-added packaging films.
Uflex Results Update
UFlex Limited reported consolidated net revenue of ₹5,397.2 Crore and net profit of ₹423.3 Crore for Q1 FY27, reflecting strong operational performance.
Uflex Q1 FY27 Results: Net Profit ₹423.3 Cr, Up 629.8% YoY
Uflex Ltd reported revenue from operations of ₹5,366 Cr (+37.6% YoY) and net profit of ₹423.3 Cr (+629.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹423.3 Cr · +629.8% YoY
Uflex Other Announcement
Uflex Limited received an ESG rating of 61/100, categorized as Strong, from ESG Risk Assessments and Insights Limited. The rating was assigned voluntarily based on public data.